TITLE

Wondering What You Missed in BioWorld Insight?

PUB. DATE
March 2013
SOURCE
BioWorld Today;3/27/2013, Vol. 24 Issue 58, p8
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
This section offers news briefs on the pharmaceutical and biotechnology sector including Galena Biopharma Inc. entering the commercial market with a deal to sell Orexo AB's Abstral (fentanyl) for 15 million U.S. dollars and the launch of an open online course called "Epidemics: the Dynamics of Infectious Diseases" by Penn State University.
ACCESSION #
86442015

 

Related Articles

  • Financing Roundup.  // BioWorld Today;4/17/2012, Vol. 23 Issue 74, p2 

    This section offers news briefs on the pharmaceutical industry, including the plan of Allon Therapeutics Inc. to raise an estimated 10 million Canadian dollars in a brokered private placement and the closure of a public offering of an estimated 9.75 million shares by Galena Biopharma Inc. with...

  • Long Wait for Data, Galena Buys Drug to Go Commercial. Orelli, Brian // BioWorld Insight;3/25/2013, Vol. 21 Issue 13, p2 

    The article focuses on acquisition strategy applied by Lake Oswego, Orlando-based Galena Biopharma Inc. They bought U.S. Food and Drug Administration approved Orexo AB's Abstral sublingual tablet and distribution rights of Teva Pharmaceutical Industries Ltd.'s Fentora tablet and Actiq...

  • Galena Biopharma Launches NeuVax.com.  // Online Product News;Mar2012, Vol. 31 Issue 3, p1 

    The article offers information on NeuVax breast cancer vaccine from Galena Biopharma.

  • FINANCINGS. Shaffer, Catherine // BioWorld Today;9/19/2013, Vol. 24 Issue 180, p5 

    The article reports on the closure of an underwritten public offering of 17.5 million shares of common stock by biotechnology firm Galena Biopharma Inc.

  • Financings Roundup.  // BioWorld Today;9/24/2013, Vol. 24 Issue 183, p2 

    The article reports that Portland, Oregon-based Galena Biopharma Inc. has purchased an additional 2.625 million shares of common stock of Galena.

  • GSK Vote Set On Exchange Of Assets With Novartis.  // Chain Drug Review;12/8/2014, Vol. 36 Issue 20, p87 

    The article offers news briefs related to the pharmaceutical industry in the U.S. including GlaxoSmithKline PLC asked shareholders to vote on its proposed deal with Novartis AG, Cystic Fibrosis Foundation sold royalty rights, and Knight Therapeutics sold its voucher to Gilead Sciences.

  • Update.  // Medical Marketing & Media;Dec2014, Vol. 49 Issue 12, p11 

    The article offers news briefs related to pharmaceutical industry in the U.S. as of December 2014 including Dendreon filed for Chapter 11 bankruptcy, Publicis Groupe offered to acquire Sapient, and Bayer Consumer Care is moving to other agencies for its over-the-counter (OTC) business.

  • Galena Adds Oncology Expert to Scientific Board.  // Biotech Business;Jul2012, Vol. 25 Issue 7, p7 

    The article announces the appointment of Doctor Gabriel N. Hortobagyi to the Scientific Advisory Board of Galena Biopharma Inc.

  • Financings Roundup.  // BioWorld Today;4/6/2012, Vol. 23 Issue 67, p6 

    This section offers news briefs on financing deals in the biopharmaceutical sector including the 12.75 million U.S. dollars in funding raised by Galena Biopharma Inc. via a public offering of shares, the registered direct offering closed by Nile Therapeutics Inc., and a plan by Savient...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics